AGAPE ATP CORPORATION Defined Contribution Plan, Cost
AGAPE ATP CORPORATION (ATPC) reported Defined Contribution Plan, Cost of $57.30 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2024-11-14
- AGAPE ATP CORPORATION defined contribution plan, cost for the quarter ending 2024-09-30 was $57.30K, a 54.10% increase year-over-year.
- AGAPE ATP CORPORATION defined contribution plan, cost for the quarter ending 2024-06-30 was $25.33K, a 29.17% decline year-over-year.
- AGAPE ATP CORPORATION defined contribution plan, cost for the quarter ending 2024-03-31 was $30.09K, a 31.17% decline year-over-year.
- AGAPE ATP CORPORATION defined contribution plan, cost for the quarter ending 2023-09-30 was $37.19K.
| Period end | Defined Contribution Plan, Cost 3 month | Defined Contribution Plan, Cost 6 month | Defined Contribution Plan, Cost 9 month |
|---|---|---|---|
| 2024-09-30 | $57.30K 10-Q · filed 2024-11-14 | $82.63K derived: sum of 2 quarters · filed 2024-11-14 | $87.39K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $25.33K 10-Q · filed 2024-08-14 | $55.41K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $30.09K 10-Q · filed 2024-05-14 | ||
| 2023-09-30 | $37.19K 10-Q · filed 2024-11-14 | $72.95K derived: sum of 2 quarters · filed 2024-11-14 | $116.66K 10-Q · filed 2024-11-14 |
| 2023-06-30 | $35.76K 10-Q · filed 2024-08-14 | $79.47K 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $43.71K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |